Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy Syndromes
Serum concentrations of leucine-rich alpha-2 glycoprotein 1 (LRG1) are elevated in several cardio-metabolic and inflammatory diseases. LRG1 also plays an important role in the development of hepatic steatosis and insulin resistance. In lipodystrophies (LDs), severe cardio-metabolic complications can...
Saved in:
Main Authors: | Michelle Krienke, Susan Kralisch, Leonie Wagner, Anke Tönjes, Konstanze Miehle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/14/11/1474 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selection of anti-cytokine biologics by pretreatment levels of serum leucine-rich alpha-2 glycoprotein in patients with inflammatory bowel disease
by: Takahiro Amano, et al.
Published: (2024-11-01) -
Early change in serum leucine-rich α-2-glycoprotein predicts clinical and endoscopic response in ulcerative colitis
by: Ryo Karashima, et al.
Published: (2024-10-01) -
Leucine-rich alpha-2 glycoprotein in combination with C-reactive protein for predicting endoscopic activity in Crohn’s disease: a single-centre, cross-sectional study
by: Yoshiaki Takada, et al.
Published: (2025-12-01) -
Leucine-rich alpha-2-glycoprotein 1 deficiency suppresses ischemia–reperfusion injury-induced renal fibrosis
by: Naohito Okami, et al.
Published: (2025-01-01) -
Efficacy of serum leucine-rich alpha-2 glycoprotein in predicting findings of Crohn’s disease small bowel lesion in capsule endoscopy
by: Teppei Omori, et al.
Published: (2024-10-01)